Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretionex vivo
2016 ◽
Vol 173
(9)
◽
pp. 1452-1464
◽
2011 ◽
Vol 650
(1)
◽
pp. 178-183
◽
Keyword(s):
2018 ◽
Vol 61
(24)
◽
pp. 11039-11060
◽
2015 ◽
Vol 746
◽
pp. 50-55
◽
Keyword(s):
Keyword(s):